Neuronal and glial dysfunction, white matter hyperintensities and cognition in ageing and Alzheimer’s disease is a research paper published in Brain Communications (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: R01AG068882
National Institutes of Health
Grant: U19 AG024904
NIA NIH HHS
Grant: U01 AG024904
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01AG068882-03
Contributions of modifiable physical attributes to cognitive and brain aging
ADNI
Janssen Alzheimer Immunotherapy Research & Development, LLC
Northern California Institute for Research and Education
Pfizer Inc.
Cogstate
Neurotrack Technologies
Transition Therapeutics
Alzheimer’s Drug Discovery Foundation
Canadian Institutes of Health Research
Lundbeck
National Institute of Biomedical Imaging and Bioengineering
Novartis Pharmaceuticals Corporation
Piramal Imaging
AbbVie
Biogen
Elan Pharmaceuticals, Inc.
Ohio State University Discovery Themes Chronic Brain Injury Initiative
Araclon Biotech
BioClinica, Inc.
Eli Lilly and Company
Foundation for the National Institutes of Health
Fujirebio
Meso Scale Diagnostics, LLC
Alzheimer’s Disease Neuroimaging Initiative
Bristol-Myers Squibb Company
EuroImmun
FNIH
GE Healthcare
IXICO Ltd.
Alzheimer’s Association
CereSpir, Inc.
Eisai Inc.
F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
Lumosity
Merck & Co., Inc.
Servier
Takeda Pharmaceutical Company
Fields of Study
Keywords